title: JAK/STAT Pathway Inhibitors and Neurologic Toxicity: Above All Else Do No Harm?
authors.affiliation: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle2Division of Medical Oncology, University of Washington, Seattle.
authors.forename: Bart L
authors.initials: BL
authors.lastname: Scott
authors.affiliation: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle3Division of Hematology, University of Washington, Seattle.
authors.forename: Pamela S
authors.initials: PS
authors.lastname: Becker
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006801:Humans; D055728:Primary Myelofibrosis / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage*; D011759:Pyrrolidines / Q000008:administration & dosage*; D013163:Splenomegaly / Q000188:drug therapy*; D013449:Sulfonamides / Q000008:administration & dosage*
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D011759:Pyrrolidines; D013449:Sulfonamides